2m 2m 2m 2m 2m 2m 2m
National Healthc (NHC)
NYSE
$197.00-$4.40 (-2.18%)
Price as of Jun 23, 2026 6:29 PM EDT- $3.1BMarket Cap
- 93.01%1-Year Change
- Medical Care FacilitiesIndustry
National Healthc (NHC)
$197.00-$4.40 (-2.18%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.5B +16.09% | 1.3B +14.53% | 1.1B +5.14% | 1.1B +1.06% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.5B +16.09% | 1.3B +14.53% | 1.1B +5.14% | 1.1B +1.06% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 44.9M +6.99% | 42.0M -0.12% | 42.0M +3.82% | 40.5M -0.45% | |
Total Operating Expenses | 1.4B +13.74% | 1.2B +12.65% | 1.1B +2.90% | 1.1B +2.98% | |
Operating Profit | 128.4M +49.66% | 85.8M +50.10% | 57.1M +79.13% | 31.9M -37.37% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -4.1M +1,176.23% | -324,000 -42.45% | -563,000 -33.37% | |
Interest Income and Expense and Net | 0 +100.00% | -4.1M +1,176.23% | -324,000 -42.45% | -563,000 -33.37% | |
Total Nonoperating Income and Expense | 18.1M -8.04% | 19.7M +18.19% | 16.7M +49.54% | 11.1M -37.32% | |
Income before Taxes | 162.4M +19.08% | 136.4M +53.72% | 88.7M +225.87% | 27.2M -81.85% | |
Income Taxes | 39.8M +16.04% | 34.3M +46.36% | 23.4M +223.27% | 7.3M -33.76% | |
Extraordinary Items | N/A N/A | N/A N/A | 0 +100.00% | -3.7M -145.33% | |
Net Income | 120.0M +17.75% | 101.9M +52.59% | 66.8M +197.61% | 22.4M -83.80% | |
Net Income from Continuing Operations Applicable to Common | 162.4M +19.08% | 136.4M +104.21% | 66.8M +197.61% | 22.4M -83.80% | |
Basic EPS and Net Income | 7.76 +17.22% | 6.62 +51.83% | 4.36 +198.63% | 1.46 -83.83% | |
Diluted EPS and Net Income | 7.67 +17.46% | 6.53 +50.46% | 4.34 +199.31% | 1.45 -83.87% | |
Basic Weighted Average Shares | 15.5M +0.51% | 15.4M +0.55% | 15.3M -0.65% | 15.4M +0.41% | |
Diluted Weighted Average Shares | 15.6M +0.31% | 15.6M +1.44% | 15.4M -0.45% | 15.4M +0.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 92.8M +21.95% | 76.1M -28.91% | 107.1M +82.51% | 58.7M -45.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 92.8M +21.95% | 76.1M -28.91% | 107.1M +82.51% | 58.7M -45.48% | |
Total Current Assets | 461.8M +8.82% | 424.4M +4.47% | 406.2M +14.78% | 353.9M -17.04% | |
Accumulated Depreciation | 635.1M +6.30% | 597.4M -1.79% | 608.4M +5.86% | 574.7M +5.77% | |
Property and Plant and Equipment and Net | 673.8M -1.53% | 684.3M +38.71% | 493.3M -2.61% | 506.5M -2.78% | |
Total Long-Term Assets | 390.8M -6.00% | 415.7M +1.09% | 411.2M -0.90% | 415.0M -8.95% | |
Total Assets | 1.5B +0.13% | 1.5B +16.30% | 1.3B +2.77% | 1.3B -9.12% | |
Income Taxes Payable | 42.7M +20.08% | 35.5M +106.69% | 17.2M +57.67% | 10.9M +59.21% | |
Total Short-Term Debt | 7.5M 0.00% | 7.5M N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 253.6M +8.02% | 234.8M +9.47% | 214.5M +8.38% | 197.9M -24.82% | |
Total Long-Term Debt | 32.5M -74.90% | 129.5M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 18.0M +6.62% | 16.9M -35.89% | 26.4M +32.21% | 20.0M +20.41% | |
Total Liabilities | 451.9M -16.51% | 541.3M +35.21% | 400.3M +0.60% | 397.9M -19.60% | |
Retained Earnings | 833.0M +10.74% | 752.2M +9.39% | 687.6M +4.71% | 656.7M -1.86% | |
Total Stockholders Equity | 1.1B +9.04% | 980.2M +7.86% | 908.8M +3.94% | 874.3M -3.18% | |
Total Shares Outstanding | 15.5M +0.56% | 15.5M +0.65% | 15.4M -0.05% | 15.4M -0.61% | |
Cash Flow | |||||
Cash from Operating Activities | 185.1M +72.48% | 107.3M -3.52% | 111.2M +1,172.20% | 8.7M -85.99% | |
Capital Expenditures | 36.4M +32.05% | 27.6M -1.08% | 27.9M -7.61% | 30.2M -23.35% | |
Cash from Investing Activities | -33.9M -85.70% | -236.7M +1,247.30% | -17.6M +193.88% | -6.0M -90.93% | |
Dividends Paid | 38.7M +4.71% | 37.0M +3.95% | 35.6M +2.76% | 34.6M +8.04% | |
Cash from Financing Activities | -136.0M -235.49% | 100.3M +335.85% | -42.5M -10.70% | -47.6M +35.10% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 8.46% +28.92% | 6.56% +31.06% | 5.01% +70.37% | 2.94% -38.03% | |
Return on Assets | 7.87% +9.42% | 7.19% +39.19% | 5.17% +208.27% | 1.68% -83.28% | |
Return on Equity | 11.71% +8.55% | 10.79% +44.04% | 7.49% +196.64% | 2.53% -84.53% | |
Revenue Growth | 16.09% +10.78% | 14.53% +182.64% | 5.14% +382.85% | 1.06% -76.25% | |
Current Ratio | 1.82 +0.73% | 1.81 -4.57% | 1.89 +5.90% | 1.79 +10.34% | |
Cash Ratio | 0.37 +12.89% | 0.32 -35.06% | 0.50 +68.36% | 0.30 -27.47% | |
Debt-to-Equity Ratio | 0.04 -73.25% | 0.14 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.03 -70.86% | 0.09 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow